The Viewpoint

Daniel Romo, MD, left, and Dan Gulick, a PhD in bio medical engineering, pose for a portrait on Jan. 8, 2017 in Minneapolis, Minn. Together they formed Aucta Technologies, a startup that is creating a novel method and medical device known as decima to non-invasively stimulate nerves in order to treat a range of diseases, including diabetes. They estimate their device, after appropriate medical testing, could be available to the public in about three years. (David Joles/Minneapolis Star Tribune/TNS)

Doctor and biomedical engineer team up on nerve stimulation device

February 28, 2017

By Alex Van Abbema Star Tribune (Minneapolis) (TNS) MINNEAPOLIS — Daniel Romo and Daniel Gulick, the young scientists behind the Minneapolis-based startup Aucta Technologies, are used to being flexible...

Load More Stories

Comments (0)

All The Viewpoint Picks Reader Picks Sort: Newest
Activate Search
diabetes